Compare BJ & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BJ | SNN |
|---|---|---|
| Founded | 1984 | 1856 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Department/Specialty Retail Stores | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.9B | 12.6B |
| IPO Year | 2018 | 2002 |
| Metric | BJ | SNN |
|---|---|---|
| Price | $93.84 | $29.83 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 15 | 2 |
| Target Price | ★ $108.36 | $36.25 |
| AVG Volume (30 Days) | 1.4M | ★ 1.5M |
| Earning Date | 05-21-2026 | 03-16-2026 |
| Dividend Yield | N/A | ★ 2.48% |
| EPS Growth | ★ 9.50 | N/A |
| EPS | ★ 1.10 | N/A |
| Revenue | ★ $21,457,274,000.00 | N/A |
| Revenue This Year | $8.86 | $8.58 |
| Revenue Next Year | $6.50 | $5.60 |
| P/E Ratio | $84.92 | ★ $64.97 |
| Revenue Growth | ★ 4.66 | N/A |
| 52 Week Low | $83.21 | $28.56 |
| 52 Week High | $107.62 | $38.79 |
| Indicator | BJ | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 50.03 | 44.11 |
| Support Level | $89.12 | $29.24 |
| Resistance Level | $94.63 | $31.18 |
| Average True Range (ATR) | 2.20 | 0.53 |
| MACD | -0.60 | -0.16 |
| Stochastic Oscillator | 20.28 | 9.59 |
BJ's Wholesale Club, founded in 1984, operates a membership-based warehouse club model primarily along the US East Coast, with roughly 260 clubs and a growing domestic presence across 21 states. In fiscal 2025, the company generated over $21 billion in revenue. BJ's offers a value-oriented assortment skewed toward grocery, perishables, and consumables (72% of sales), general merchandise (11%), and gasoline (17%). Its business model is supported by recurring membership fee income and private-label brands such as Wellsley Farms and Berkley Jensen.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 40% of the UK-based firm's revenue comes from orthopedic products, and another 31% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the US, just over 30% is from other developed markets, and emerging markets account for the remainder.